C. obtusa, an essential oil produced in Jeollanamdo Gangjin, is the most effective plant oil for easing Sick House Syndrome, having an effect similar to a therapeutic walk in the woods and acting as a sterilizer. In light of its medicinal importance, its composition, antibacterial activity and ability to mitigate an offensive odor have been analyzed. Through GC-MS, I confirmed that it contains approximately 50 components, 80.30% of which are various monoterpenes. It was effective at alleviating malodors from formaldehyde, ammonia, trimetylamine and methylmercaptan as determined in colorimetric gas detection tube tests in comparison with lemongrass and clove leaf essential oil. I obtained from Minimal Inhibition Concentration(MIC) of C. obtusa, higher concentrations will lead to increased antibacterial activity. Therefore it is estimated that utility value of it will be grow more and more.

Hydroxyapatite (HAp) and biphasic calcium phosphate (BCP) nano powders were synthesized using the microwave-assisted synthesis process dependent on pH and microwave irradiation time. The average size of a powder was less than 100 nm in diameter. Through in-vitro cytotoxicity tests by an extract dilution method, the HAp and BCP nano powders have shown to be cytocompatible for L-929 fibroblast cells, osteoblastlike MG-63 cells and osteoclast-like Raw 264.7 cells. The activation of osteoblast was estimated by alkaline phosphatase (ALP) activity. When the HAp and BCP were treated to MG-63 cells, alkaline phosphatase activities increased on day 3, compared with those of the untreated cells. Also, the collagen fibers increased when the HAp and BCP powders suspension were treated to MG-63 cells, compared to those of the untreated cells. Quantitative alizarin red S mineralization assays showed a trend toward increasing mineralization in osteoblast cultured with powder suspension. In conclusion, hydroxyapatite and biphasic calcium phosphate appeared to be a bone graft substitute material with optimal biocompatibility and could be further applied to clinical use as an artificial bone graft substitute.